McKesson Corporation (MCK) financials
McKesson revenue and earnings by year
McKesson's revenue was $403 billion in the fiscal year to March 31, 2026, up 12.4% from the year before. Net income was $4.76 billion, 1.2% of revenue. Since the fiscal year to March 31, 2017, revenue has grown 8.2% a year on average.
Fiscal years, each labelled by the calendar year it ended in.
Income statement, the last 10 fiscal years
| Fiscal year to | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 403.4 | 359.1 | 309.0 | 276.7 | 264.0 | 238.2 | 231.1 | 214.3 | 208.4 | 198.5 |
| Revenue growth | 12.4% | 16.2% | 11.7% | 4.8% | 10.8% | 3.1% | 7.8% | 2.9% | 4.9% | — |
| Gross profit | 14.6 | 13.3 | 12.8 | 12.4 | 13.1 | 12.1 | 12.0 | 11.8 | 11.2 | 11.3 |
| Gross margin | 3.6% | 3.7% | 4.2% | 4.5% | 5.0% | 5.1% | 5.2% | 5.5% | 5.4% | 5.7% |
| Operating income | 6.2 | 4.4 | 3.9 | 4.4 | 2.0 | -5.0 | 2.5 | 0.9 | 0.6 | 3.2 |
| Operating margin | 1.5% | 1.2% | 1.3% | 1.6% | 0.8% | -2.1% | 1.1% | 0.4% | 0.3% | 1.6% |
| Net income | 4.8 | 3.3 | 3.0 | 3.6 | 1.1 | -4.5 | 0.9 | 0.0 | 0.1 | 5.1 |
| Net margin | 1.2% | 0.9% | 1.0% | 1.3% | 0.4% | -1.9% | 0.4% | 0.0% | 0.0% | 2.6% |
| Diluted EPS | $38.38 | $25.72 | $22.39 | $25.03 | $7.23 | -$28.62 | $5.13 | — | — | $23.33 |
| Free cash flow | 5.4 | 5.2 | 3.6 | 4.6 | 3.9 | 3.9 | 3.9 | 3.5 | 3.8 | 4.2 |
Diluted EPS is stated in today's shares (adjusted for every split since). Quarterly statements and the income statement as a flow chart are in the app: open MCK in Markets.
How McKesson makes money
Revenue by segment in the quarter to June 30, 2026, as the company reports it.
| Segment | Revenue | Share |
|---|---|---|
| North American Pharmaceutical | $86.8B | 82.3% |
| Oncology & Multispecialty | $14.2B | 13.5% |
| Medical Surgical Solutions | $2.82B | 2.7% |
| Prescription Technology Solutions | $1.57B | 1.5% |
See also: MCK valuation and P/E history · MCK returns
No forecast, no recommendation. This page describes McKesson Corporation from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.